Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy-Reference-Cited by-同舟云学术

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy

Published:2019-09-02 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Hong Sung Pil,Chan Thalia E.,Lombardo Ylenia,Corleone Giacomo,Rotmensz Nicole,Bravaccini Sara^ORCID,Rocca Andrea^ORCID,Pruneri Giancarlo,McEwen Kirsten R.^ORCID,Coombes R. Charles,Barozzi Iros,Magnani Luca^ORCID

Funder

Cancer Research UK

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-11721-9.pdf

Reference63 articles.

1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378, 771–784 (2011).

2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386, 1341–1352 (2015).

3. Asselain, B. et al. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 19, 27–39 (2018).

4. Pan, H. et al. 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N. Engl. J. Med. 377, 1836–1846 (2017).

5. Casasent, A. K. et al. Multiclonal invasion in breast tumors identified by topographic single cell sequencing. Cell 172, 205–217.e12 (2018).

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis;Drug Resistance Updates;2024-09

2. Palliative surgery versus non-surgery of the solitary metastatic lesion in De novo metastatic breast cancer: A SEER based study;Medicine;2024-06-21

3. Oncogenic composite mutations can be predicted by co‐mutations and their chromosomal location;Molecular Oncology;2024-05-16

4. A Functional Survey of the Regulatory Landscape of Estrogen Receptor–Positive Breast Cancer Evolution;Cancer Discovery;2024-05-16

5. Identifying Key Regulatory Genes in Drug Resistance Acquisition: Modeling Pseudotime Trajectories of Breast Cancer Single-Cell Transcriptome;Cancers;2024-05-15